2024
   
    
    
    	
    				 			 			 			 			 			 	
    	
    	
	
	
   	        
	
			
		    	    	     		     	       		     		     	       		     		     	       		     		     	       		     		     			     
 	    	    	     		     	      			      	  				  			       		     		     	       		     		     	       		     		     	       		     		     			     
 	    	    	     		     	       		     		     	      			      	  				  			       		     		     	       		     		     	       		     		     			     
 	    	    	     		     	       		     		     	       		     		     	      			      	  				  			       		     		     	       		     		     			     
 	    	    	     		     	       		     		     	       		     		     	       		     		     	      			      	  				  			       		     		     			     
 	    	    	     		     	       		     		     	       		     		     	       		     		     	       		     		     			     
 	    		
	
	    		     
		     		     
		     	 		     	
 	    		     
		     	
 	    		     
		     	
 	    		     
		     	
 	    		     
		     	
 	    		     
		     		     
		     	 		     	
 	    
	
	   	                
	    	    		    	     		     	      			      	  				  				  
			       		      	        	    	     		     	       		      	        	    	     		     	       		      	        	    	     		     	       		      	        	    	     		     	       		      	        	    	     		     	       		      	        	    	
    
    
    
    	
   	   
	
   	   	   	   
	   	
   	   	       	    
       	           	    	           	    	    			    		       						       	    	    	       						       	    	    	       						       	       	
    
    
    
    Market Introduction Processes
	Name: Market Introduction Processes
      
      
	Code: CMS14609O
      
      
	3 ECTS
      
      
	Duration: 15 weeks/78 hours
      
      
	Scientific Area:
	
	      
	      
	      	      	  		  	      	  		  	   	      	  	   			   
		  		  Ciências Farmacêuticas
	      	
      
      
	Teaching languages: Portuguese
      
            	        	  	   	        	  	   	        	  	   	        	  	   	              
      
	Languages of tutoring support: Portuguese, English
      
                  
	Regime de Frequência: E-learning
      
      
      
            	  Presentation
		     This curricular unit addresses the different phases and procedures of the registration and marketing authorisation processes for medicines and medical devices, including borderline products.
		
	  Sustainable Development Goals
Learning Goals
		  		      The main objective of the curricular unit is to carry out a regulatory and procedural approach to the processes of market introduction of medicines and medical devices, as well as the borderline cases between them. Students should acquire knowledge and skills in terms of the different phases and procedures of the registration and authorization processes for medicines and medical devices. They should also be able to identify borderline cases, as well as analyze them and understand the differences between different examples.
		  		
	  Contents
		  		      1.	PT and EU regulatory framework: medicines and medical devices.
2. National and European authorities.
3. Medicines for human use:
a. Marketing Authorization Procedures (MA)  EU and PT.
b. MA file (common technical document).
c. Modification and revocation of the MA file.
d. Adaptive pathways.
e. Priority medicines (PRIority MEDIcines, PRIME programme).
f. Generic and biosimilar medicines.
4. Medical devices:
a. Definition, classification, and demarcation of borders.
b. Competent authority notified body and associations.
c. CE marking.
d. Essential requirements and harmonized standards.
e. Supporting technical documentation.
f. Compliance assessment.
g. Conformity declaration.
h. Registration, encoding, traceability and unique identification.
5. Common points/different
		  		
	  2. National and European authorities.
3. Medicines for human use:
a. Marketing Authorization Procedures (MA)  EU and PT.
b. MA file (common technical document).
c. Modification and revocation of the MA file.
d. Adaptive pathways.
e. Priority medicines (PRIority MEDIcines, PRIME programme).
f. Generic and biosimilar medicines.
4. Medical devices:
a. Definition, classification, and demarcation of borders.
b. Competent authority notified body and associations.
c. CE marking.
d. Essential requirements and harmonized standards.
e. Supporting technical documentation.
f. Compliance assessment.
g. Conformity declaration.
h. Registration, encoding, traceability and unique identification.
5. Common points/different
Teaching Methods
		  		      Classes take place in face-to-face sessions (9h): divided into three classes  inaugural, workshop and evaluation; the rest (21h) being carried out remotely. The teaching methodology will be centered on dynamic learning based on the presentation of fundamental concepts, followed by theoretical-practical sessions of work discussion involving: a) discussion and critical analysis of scientific articles; b) simulation of practical cases. The features of Moodle, videos and other synchronous and asynchronous methodologies considered adequate to the pedagogical objectives of the curricular unit will be used.
		  		
	  Assessment
		  		      The final assessment results from the continuous assessment of the work developed/presented/discussed throughout the course (40%) and a final written work (60%).
		  		
	  Teaching Staff
- Ana Margarida Molhinho Advinha [responsible]
 - Cátia Moreira de Sousa
 
            
    
    
      
            
    
    
      
            
    
    
      
            
    
    
      
            
    
    
      
            
    
    
      
            
    
    
      
            
    
    
      
            
    
    
      
            
    
    
      
            
    
    
      